Banco Santander’s Pacira BioSciences PCRX Stock Holding History

Banco Santander’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.21M	Hold	166,000	–	–	0.03%	229
2026 Q1	$3.75M	Buy	166,000 +10,000	+6%	+$222K	0.03%	220
2025 Q4	$4.04M	Buy	156,000 +3,000	+2%	+$71.3K	0.03%	214
2025 Q3	$3.94M	Buy	153,000 +17,000	+13%	+$418K	0.04%	220
2025 Q2	$3.25M	Sell	136,000 -6,000	-4%	-$151K	0.03%	230
2025 Q1	$3.53M	Buy	142,000 +15,100	+12%	+$362K	0.04%	220
2024 Q4	$2.39M	Buy	126,900 +6,900	+6%	+$121K	0.03%	226
2024 Q3	$1.81M	Sell	120,000 -18,373	-13%	-$314K	0.02%	240
2024 Q2	$3.96M	Buy	+138,373	New	+$3.94M	0.05%	191

Other funds holding PCRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DPCM

Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Banco Santander's PCRX Position: Q2 2026 in Review

Banco Santander held its Pacira BioSciences (PCRX) position steady in Q2 2026 at 166,000 shares worth $4.21M. The position accounts for 0.03% of the portfolio, ranked #229.

Banco Santander first reported a position in PCRX in Q2 2024 and has held it in 9 quarters since. 253 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.

Banco Santander held 166,000 shares of Pacira BioSciences worth $4.21M as of Q2 2026.
Banco Santander left its Pacira BioSciences share count unchanged in Q2 2026.
Pacira BioSciences made up 0.03% of Banco Santander's portfolio in Q2 2026, its #229 holding.
Banco Santander first reported a position in Pacira BioSciences in Q2 2024 and has held it in 9 quarters since.
253 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.

Based on Banco Santander's 13F filing for Q2 2026, filed 29 Jul 2026.